The authors are of the opinion that despite GBP therapy not affecting tumor development, the effects of GBP at the molecular level, such as increased SOD activity, IL-6 and MCP-1 levels and reduced arginase activity, may have a positive effect on the patients’ general condition [61]. The gene discussed is CCL2; the disease is neoplasm.